In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
about
Epidemiology and Control of Strawberry Bacterial Angular Leaf Spot Disease Caused by Xanthomonas fragariaeComparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adultsComparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacinIn vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents.Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens.Use of quinolones in the treatment of gastrointestinal infections.Multicenter evaluation of the proposed quality control limits and interpretive zone standards for in vitro susceptibility testing with norfloxacinThree-year prospective study of intestinal pathogens in Madrid, Spain.Characterization of the porins of Campylobacter jejuni and Campylobacter coli and implications for antibiotic susceptibilityCiprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Sequence analysis of the gyrA and parC homologues of a wild-type strain of Vibrio parahaemolyticus and its fluoroquinolone-resistant mutants.Norfloxacin: clinical pharmacology and clinical use.Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers.In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.Antibacterial activity of norfloxacin in the gastrointestinal tracts of ratsComparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.Norfloxacin and Salmonella excretion in acute gastroenteritis--a 6-month follow-up study.Comparison of the in vitro activity of ciprofloxacin (Bay o 9867) and norfloxacin against gastrointestinal tract pathogens.Pharmacokinetics and tissue residues of norfloxacin and its N-desethyl- and oxo-metabolites in healthy pigs.
P2860
Q28828300-5E616DA5-0B52-4DB9-BDC2-E9A4F37A7BCDQ33739402-60D1AED7-D311-4C8A-B1A5-1E132AAD86CFQ35256507-7F340F42-8D80-4954-A701-D1E3DF55026CQ35566514-AFBB62F4-B14B-4FFC-817A-40222B9AD111Q35570699-A6B7B11E-236A-4C15-81D0-AAEB8F5D4157Q35575634-BA78891F-59CF-4F3F-9FA0-25C202EABC52Q35646935-63559BAE-5EB7-458A-A566-11C500A81212Q35759234-57779845-6E29-4E48-A9AB-65F5DB36D404Q37222600-6CD55BF2-24BC-470F-BB50-5F0DECA81956Q37258777-2EA30AE1-4949-471C-B882-A843CCB4D109Q37267941-469E7CF8-C046-40B3-A70D-30B1BD39D5FFQ38272526-01564503-1D63-4F79-8A23-6829BFF252B2Q39214819-671BFBE9-9CF9-4A69-A419-C0347CEC9429Q39470084-9296138D-4D6F-4D3B-8FB3-DA8A6CEF9F48Q39681144-DBA7817F-4EF9-4E21-98EC-8230CF807FE2Q39848971-20643E7E-10B3-446B-82A5-08211F46D28EQ41858315-5D7A4BF7-80ED-417A-8FD1-716135F68AC3Q42279475-E8D613E2-5B2F-4233-AD0D-5C7EF4D0CFCDQ43840994-223EAF86-2114-4F72-AD9A-2EFB5B7E08ADQ50140918-87D96966-AA23-4EC8-ABDF-23B9C05D84ABQ50207861-12720CD7-6D1F-40D3-BA3C-77911C9D080BQ54008697-26551F54-B0CC-4839-A5E0-AF775DB8282C
P2860
In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
In vitro antibacterial activit ...... trointestinal tract pathogens.
@ast
In vitro antibacterial activit ...... trointestinal tract pathogens.
@en
type
label
In vitro antibacterial activit ...... trointestinal tract pathogens.
@ast
In vitro antibacterial activit ...... trointestinal tract pathogens.
@en
prefLabel
In vitro antibacterial activit ...... trointestinal tract pathogens.
@ast
In vitro antibacterial activit ...... trointestinal tract pathogens.
@en
P2093
P2860
P356
P1476
In vitro antibacterial activit ...... trointestinal tract pathogens.
@en
P2093
Gadebusch HH
Weinberg E
P2860
P356
10.1128/AAC.23.1.86
P407
P577
1983-01-01T00:00:00Z